Rega marang bathi mangsa ngarep: Telesis Bio, Inc. (TBIO)
Telesis Bio, Inc. (TBIO) generates revenue through the sale of automated DNA synthesizers and consumables, ensuring a steady cash flow. The shift in the company's forward P/E ratio on the GURU.Markets chart reflects market expectations, where the 0.00 mark indicates the valuation level. Meanwhile, the productivity of the BioXp platform development is being offset by pressure from major laboratory equipment market behemoths.
Rincian metrik keuangan lan pasar Telesis Bio, Inc (TBIO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Telesis Bio, Inc.|TBIO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Telesis Bio, Inc.|TBIO - Utang perusahaan|Utang-utang marang kapitalisasi buku Telesis Bio Inc.|TBIO - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Telesis Bio|Indikator likuiditas cepet telesisbio.com
- statistik bathi lan rasio pasar:
TBIO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Telesis Bio, Inc.|TBIO - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Codex DNA|TBIO - Rasio P/E diaturake wutah|Pangali EV/EBITDA Telesis Bio Inc.|TBIO - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Telesis Bio|TBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan telesisbio.com|TBIO - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Telesis Bio, Inc.
Analisis umum perusahaan:Telesis Bio
For Telesis Bio, Inc. (TBIO), a developer of DNA and mRNA synthesis systems, the company's estimated forward P/E reflects market expectations for BioXp monetization amid the expansion of gene therapy. This indicator compares current market capitalization with expected annual net income, allowing a credit analyst to objectively assess the issuer's solvency and the risk of asset overvaluation before making an investment decision.
Pesaing utama
Pangali Forward P/E TEM|QGEN - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Ionis Pharma IONS|Kapitalisasi marang proyeksi bathi Repligen Inc. (RGEN)|Avidity Biosciences - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi crisprtx.com CRSP|GeneDx (WGS) - Rega marang bathi mangsa ngarep|RARE - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi BEAM|SRPT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TWST|Rega marang bathi mangsa ngarep TXG (10xgenomics.com)|Pangali Forward P/E NTLA (Intellia Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Stoke Therapeutics Inc (STOK)|BLFS - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Wave Pharma|MAZE (Maze Therapeutics Inc) - Prakiraan rega marang bathi|sionnatx.com - Pangali mangsa ngarep rega marang bathi|PRME (Prime Medicine) - Pangali Forward P/E|Taysha Gene Therapies Inc (TSHA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep uniQure Corp (QURE)|MeiraGTx Corp - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E RGNX (REGENXBIO Inc.)|SLDB - Prakiraan rega marang bathi|OCGN: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Pacific Biosciences of California, Inc. PACB|BNTC (Benitec) - Prakiraan rega marang bathi|DSGN: Rasio kapitalisasi marang bathi mangsa ngarep|RCKT (Rocket Pharmaceuticals) - Pangali Forward P/E|Rega marang bathi mangsa ngarep FDMT|Pangali Forward P/E LXEO|Kapitalisasi marang proyeksi bathi korrobio.com|Rega marang bathi mangsa ngarep Editas EDIT|Silence Therapeutics Corp (SLN) - Rasio prakiraan rega marang bathi|ProQR Therapeutics NV - Pangali Forward P/E|CDXS (Codexis, Inc.) - Rasio rega marang bathi mangsa ngarep|Sangamo Therapeutics, Inc. (SGMO) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep NAUT|MGX (Metagenomi, Inc) - Pangali Forward P/E|Pangali Forward P/E Precision BioSciences Inc.|Prakiraan rega marang bathi GBIO (Generation Bio Co.)|Rasio kapitalisasi marang bathi mangsa ngarep BOLD|Pangali Forward P/E XCUR (Exicure)|Imunon Inc (IMNN) - Rasio prakiraan rega marang bathi|PHIO - Rega marang bathi mangsa ngarep|MBIO: Rega marang bathi mangsa ngarep|RNAZ: Pangali Forward P/E|Rasio prakiraan rega marang bathi Bionano Genomics (BNGO)|Rega marang bathi mangsa ngarep Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E IPA|Kapitalisasi marang proyeksi bathi Omega Therapeutics Corp|Rega marang bathi mangsa ngarep Singular Genomics Systems OMIC|Kapitalisasi marang proyeksi bathi regulusrx.com (RGLS)|SYRS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON Pharmaceuticals Inc.)|UBX: Pangali Forward P/E
